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The origin of infrainguinal vein graft 
stenosis: A prospective study based on 
duplex surveillance 
Joseph L. Mills, MD, Dennis F. Bandyk, MD, Vivian Gahtan, MD, and 
Glenn E. Esses, MD, Tampa, Fla. 
Purpose: The purpose of this study was to determine the origin of vein graft lesions and 
their propensity for progression based on prospective duplex surveillance of 135 
infrainguinal vein bypasses. 
Methods: One hundred sixteen greater saphenous, 13 spliced, five cephalic, and one 
superficial femoral vein grafts were evaluated by color duplex imaging at surgical 
procedure, 1 and 6 weeks, 3 and 6 months, and every 3 to 6 months thereafter. 
Duplex-identified lesions were graded by peak systolic velocity and velocity ratio criteria 
and were either followed or subjected to revision. 
Results: Early postoperative duplex surveillance allowed stratification of infrainguinal 
grafts into two subsets. Of 91 (67%) grafts with normal early scans (at 3 months), only 
two (2.2%) developed e novo stenoses (at 6 and 8 months) that required revision. 
Forty-four grafts with abnormal duplex scans had a focal flow abnormality (peak systolic 
velocity > 150 cm/sec, velocity ratio > 1.5) in the graft body (n = 24) or anastomotic 
region (n = 20). In 14 grafts the flow abnormality (mean peak systolic velocity = 217 
cm/sec, velocity ratio = 2.3) normalized. Ten additional grafts exhibited a moderate, 
persistent graft stenosis (mean peak systolic velocity 248 cm/sec, velocity ratio = 3.3) that 
was not repaired. All 20 grafts with lesions that progressed tohigh-grade stenosis (mean 
peak systolic velocity = 362 cm/sec, velocity ratio = 7.2) and were revised had a residual 
flow abnormality confirmed at operation, or it appeared by 6 weeks. In the entire series 
six (4.4%) grafts failed during the mean 12-month follow-up interval (range 3 to 30 
months), 4 with unrepaired efects and two after revision. 
Conclusions: Prospective duplex surveillance verified that de novo graft stenosis was 
uncommon (< 2.2%) after reversed and in situ saphenous vein bypass grafting. Graft 
stenoses developed at sites ofunrepaired defects or early appearing conduit abnormalities. 
An early appearing duplex focal flow abnormality warranted careful surveillance, because 
one half of such sites progressed toa high-grade stenosis. Grafts with normal early duplex 
scans exhibited a low incidence of stenosis development or occlusion, and thus less intense 
postoperative surveillance can be recommended. (J Vhsc SURG 1995;21:16-25.) 
Intrinsic vein graft stcnosis is the most common 
cause of infrainguinal vein bypass failure, accounting 
for approximately 60% of graft thromboses. 1-3 The 
origins of these lesions are ill-defined. Theoretically 
unrepaired technical defects, vein valve sites, preexist- 
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ing vein conduit abnormalities, and vein wall trauma 
(clamp or vaMflotome injury, mobilization/dissec- 
tion) can serve as the nidus for myointimal hyperplasia 
or stricture formation after arterialization. If a lesion 
develops and progresses to a high-grade stenosis, 
graft flow is compromised, and thrombosis can 
shortly ensue. Graft surveillance studies have indi- 
cated that 12% to 37% ofinfrainguinal vein bypasses 
develop stenotic lesions that warrant correction. 
Most of these lesions develop without symptoms 
during the first 12 postoperative months. 4-7 Lesions 
with duplex-derived velocity spectra of a high-grade 
stenosis and greater than 70% diameter reduction by 
angiography uniformly result in graft failure, if not 
promptly corrected. 6 
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Duplex ultrasonography alone or in conjunction 
with resting ankle pressure measurements is a rec- 
ommended surveillance method after infrainguinal 
bypass graJ[ting. 5-9 At present frequent graft studies 
are advocated uring the first postoperative year, 
despite the fact that less than one quarter of grafts will 
develop alesion that threatens patency. If the origins 
of graft stenosis were better understood, screening 
grafts wi l l  duplex scanning for a precursor flow 
abnormality might permit categorization of infrain- 
guinal vein bypasses into high- and low-risk groups. 
It is generally accepted that most graft stenoses 
develop as the result of myointimal hyperplasia, but 
whether these postimplantation lesions arise de novo 
in a previously normal graft segment or require a site 
of wall trauma, thrombus formation, or preexisting 
disease as a promoter isnot known. Arterialization of 
venous conduits can produce a spectrum of wall 
abnormalities ranging from focal strictures to diffuse 
thickening or aneurysmal dilation. With time vein 
grafts also become subject to the development of 
atherosclerosis. 1 
The purpose of this study was to use duplex 
scanning as an indirect method for identifying the 
origin(s) of vein graft stenoses and determining their 
natural history. We evaluated 135 infrainguinal 
autogenous vein bypasses by duplex imaging and 
velocity spectra analysis at operation to exclude 
residual graft defects. We evaluated them serially after 
operation to detect, grade the severity, and follow 
focal flow abnormalities as they developed. This 
method permitted calculation of the incidence of 
postimplantation lesions (residual and de novo) 
relative to vein graft type or configuration and 
characterization f the temporal and hemodynamic 
characteristics of lesion progression or regression. It
was also hoped that such intensive graft surveillance 
would identify a subset of grafts that were at low risk 
for the development of graft stenosis and thrombosis, 
thereby permitting less intense surveillance. 
MATERI~LL AND METHODS 
Patient population. From August 1991 to 
December 1993 color-flow duplex scans were ob- 
tained prospectively on 135 consecutive infrainguinal 
vein grafts implanted in 125 patients in the vascular 
surgery department of the University of South 
Florida College of Medicine. The patients included 
107 (86%) men and 18 (14%) women with a mean 
age of 67.1 years (range 42 to 89 years). Excluded 
from the study were vein grafts performed for 
vascular trauma and eight grafts performed in pa- 
tients in whom graft surveillance was not possible or 
who were lost tO follow-up. The operative indica- 
tions for lower limb revascularization were critical 
limb ischemia (tissue loss, 66; ischemic rest pain, 45) 
in 111 (82%) patients, debilitating claudication i 18 
(13%) patients, and popliteal aneurysm in six (5%) 
patients. 
Operative technique and vein use in each patient 
varied with surgeon's preference and vein availability. 
In 116 (86%) procedures the greater saphenous vein 
(including contralateral leg donor veins) was used as 
a reversed conduit (n = 51), in situ bypass (n = 46), 
or in a nonreversed (valve lysed), translocated con- 
figuration (n = 19). Thirteen (9.6%) bypasses were 
constructed with spliced reversed vein (greater/lesser 
saphenous vein or arm vein) segments, and five grafts 
consisted entirely of reversed cephalic vein. One 
bypass was performed with superficial femoral vein. 
The location of the distal anastomosis were the 
above-knee popliteal artery in 28 (20%) limbs, 
below-knee popliteal artery in 45 (33%) limbs, 
infrageniculate arteries in 54 (40%) limbs, and dorsal 
pedal or plantar arteries in eight (7%) fimbs. 
Graft surveillance protocol. All patients in the 
study underwent serial postoperative duplex graft 
imaging beginning at operation (n = 100) or before 
discharge (n = 35) after infrainguinal vein bypass. 
Grafts were then evaluated within 4 to 6 weeks of the 
operation, again at 3 and 6 months, and at 6-month 
intervals thereafter. Graft surveillance was performed 
by experienced vascular technologists in accredited 
vascular laboratories under the direction of the 
authors (JLM, DFB). The technologists were not 
blinded to the results of the previous scans. The 
details of the scanning protocol have been previously 
reported. 2,9 Because a study goal was to determine 
whether vein graft lesions develop from unrepaired, 
residual technical imperfections in bypass construc- 
tion, preexisting vein conduit abnormalities, or focal 
graft lesions that develop soon after graft implanta- 
tion, all bypasses were subjected to color duplex 
imaging on at least two occasions within the first 6 
postoperative weeks. 
At operation and at scheduled postoperative 
intervals, longitudinal imaging of the entire graft 
(including proximal and distal native vessels) was 
performed with either a 5.0 or 7.5 MHz linear ar- 
ray probe. Instrumentation i cluded Ultramark 
HDI (Advanced Technology Laboratories, BotheH, 
Wash.) and Acuson 128-HP/10 (Acuson Corpora- 
tion, Smyrna, Ga.) color-flow duplex scanners. Rep- 
resentative centerstream velocity spectra (peak sys- 
tolic velocity and velocity ratio measurements) were 
routinely recorded in five segments of, the bypass: 
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Fig. 1. Duplex surveillanCe data. One hundred thirty-five infrainguinal vein grafts were 
stratified into two groups based on whether early ( < 3 month) duplex scanning results were 
normal or abnormal. Grafts with abnormal early scanning results exhibited 45% incidence of 
stenosis requiring revision, in contrast to 2% stenosis revision rate in subset of grafts with normal 
early scanning results. 
proximal anastomosis and adjacent graft, high- 
thigh, above-knee, below-knee, and distal graft and 
anastomosis. Velocity measurements were made at a 
Doppler angle of 60 degrees or less. Ira focal increase 
in systolic blood flow velocity or spectral broadening 
was noted at any site in the graft segment, avelocity 
ratio (Vr) was calculated across the lesion with an 
accepted published method. 1°'11 Duplex-derived ve- 
locity spectra criteria of stenosis included the pres- 
ence of a color "flow jet," a peak systolic velocity 
(PSV) greater than 150 cm/sec, and V r greater than 
1.5. The location and severity of such lesions were 
carefully noted and served as a baseline for compari- 
son for subsequent s udies. 
Based on intraoperative and early postoperative 
(to 3 months) duplex examinations, grafts were cat- 
egorized into two subsets: normal and abnormal. 
Normal graft scans were characterized by the demon- 
stration of PSV greater than 45 cm/sec in normal 
caliber (4 mm diameter) vein segments and an ab- 
sence of significant focal flow disturbances (PSV < 
150 cm/sec and Vr < 1.5) in the five graft segments 
evaluated. Abnormal graft scans demonstrated at 
least one site of significant focal flow disturbance. All 
abnormal vein segments were serially monitored at 
6-week to 2-month intervals for progression or re- 
gression of the flow abnormality. The postoperative 
time at which each lesion was initially detected was 
recorded. When multiple abnormal graft sites were 
detected the appearance time of graft stenosis was 
defined as the postoperative interval at which the first 
lesion was identified, termed the "index stenosis." 
Grafts characterized as normal or abnormal by the 
aforementioned criteria were carefully followed, and 
the need for subsequent revision of a high-grade ste- 
nosis (PSV > 300 cm/sec and Vr > 3.4; > 70% by 
angiography) was determined. The temporal and he- 
modynamic haracteristics of lesions that resolved or 
remained stable were compared with those of lesions 
that progressed and ultimately required revision. All 
grafts were followed for a minimum of 3 months 
(range 3 to 30 months) with an average follow-up 
time of 12 months. A mean of six duplex scans were 
obtained per bypass graft (range 3 to 14 scans). 
RESULTS 
The 135 vein grafts were stratified into two 
subsets based on the results of intraoperative and 
early postoperative duplex scans (Fig. 1). Results of 
duplex surveillance studies were entirely normal 
through 3 months in 91 (67%) grafts. This graft 
subset experienced a low incidence of sudden throm- 
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Table I. Characteristics of vein graft lesions identified by duplex surveillance 
Index lesion duplex 
characteristics ~ 
Stenosis 
subgroup No. grafts No. lesions PSV Vr 
Index lesion Average 
location time to 
% appearance resolution~repair 
Anastomosis Graft body time < 3 mos. (too) 
Stenosis resolved 16 19 
Stenosis followed 11 15 
Stenoiis repaired 22 29 
Totals 49 63 
216 (158-259) 2.3 (1.6-3.4) 
248 (160-365) 3.3 (1.2-8.2) 
362 (227-620) 7.1 (2.6-19.9) 
5 11 14 (88) 3.6 
8 3 10 (91) N/A 
10 12 20 (91) 5 
23 26 44 (90) 
PSV, Peak systolic velocity (cm/sec); Vr, velocity ratio at stenosis. 
~Mean (range). 
bosis or need for revision. Five grafts subsequently 
developed graft stenoses between 3 and 12 months 
after the operation. Two of these lesions resolved, 
and one persists but remains table during follow-up 
examinations. The remaining two grafts developed 
stenoses at 6 and 8 months that were of sufficient 
severity to require revision. One graft, a spliced, 
three-segment vein conduit that had undergone 
intraoperative revision but had normal scans at 1 and 
3 postoperative weeks, thrombosed at3 months for 
unclear easons. Three additional grafts developed 
low-flow states caused by progressive inflow disease 
without intrinsic graft stenoses at a mean of 12 
months after operation. Two of these low-flow grafts 
thrombosed during follow-up, one of which under- 
went successful thrombolysis and repeat inflow 
reconstruction performed with maintenance of sec- 
ondary patency. Therefore for the subset of bypasses 
with normal early duplex scans, the incidence of 
subsequent de novo graft stenosis requiring revision 
was 2.2% (two of 91), and the total incidence of graft 
thrombosis was 3.3% (three of 91). 
Forty-four (34%) grafts were classified as abnor- 
mal, because early focal flow disturbances (PSV 
> 150 cm/sec, V r > 1.5) were identified by duplex 
scanning. The stenosis resolved in 14 cases, remains 
stable, and is still being followed in 10 instances. It
progressed to require vein graft revision in 20 cases. 
Thus the incidence of stenosis progression requiring 
vein graft revision in this subset with abnormal early 
scans was 45% (20 of 44). Three (6.8%) grafts in this 
subset hrombosed during the follow-up period, all 
with recurrent or persistent unrepaired graft stenoses. 
Data from both subsets were then combined to 
analyze and delineate the characteristics of the vein 
graft lesions encountered. Eighty-three (61%) by- 
passes had normal duplex scans without any identi- 
fiable abnormalities during the follow-up period. 
Three grafts developed low-flow states because of 
inflow disease progression without identifiable focal 
stenoses within the vein graft. In 49 (36%) grafts at 
least one focal stenosis was detected. The stenosis 
resolved in 16 grafts. Stenoses persisted but were not 
repaired in 11 grafts. In 22 grafts prophylactic vein 
graft revision was performed because of stenosis 
progression. The hemodynamic and temporal char- 
acteristics of each of these three stenosis ubgroups 
are summarized in Table I. 
The 16 stenoses that resolved were primar- 
ily low-grade flow disturbances (mean PSV, 216 
cm/sec; Vr, 2.3) in midgraft segments. The highest 
grade flow disturbances that were detected and 
documented to resolve demonstrated a PSV of 259 
cm/sec and a V r of 3.4. Eleven (69%) lesions were 
midgraft and were thought o represent turbulence 
at valve sites. Five lesions were juxtaanastomotic. Of 
interest was the finding that most of the lesions that 
resolved occurred in reversed vein conduits (11 
reversed, three spliced vein, and two in situ con- 
duits). These lesions were detected early after 
implantation; 13 (81%) of 16 appeared by the 
6-week postoperative scan, and i4 (88%) of 16 
appeared by 3 months (Fig. 2). All lesions that 
ultimately resolved did so by the twelfth postop- 
erative month: 11 (69%) of 16 within 3 months 
and 14 (88%) of 16 within 6 months of their 
appearance. No graft in this subset thrombosed 
during the follow-up period. 
Eleven vein grafts (four in situ, six reversed, one 
spliced) harbored 15 lesions that were followed and 
not repaired. The 11 index (first appearing) lesions 
developed in the juxtaanastomotic position in eight 
grafts and at midgraft sites in three. Duplex-derived 
velocity characteristics were intermediate in severity 
(mean PSV, 248 cm/sec; Vr, 3.3). These lesions also 
appeared early: 73% by 6 weeks and 91% by 3 
months after the operation. 
Twenty-two grafts required 29 revisions because 
of stenosis everity and progression. Most lesions 
were solitary; 18 grafts underwent one revision for 
a single lesion, three grafts required six revisions 
for tandem lesions, and one graft required five 
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Fig. 2. Appearance time of index (first appearing) graft stenoses. 
revisions for multiple metachronous tenoses. 
Duplex-detected velocity disturbances were severe 
(mean PSV, 362 cm/sec; Vr, 7.1). Of the 22 index 
lesions 10 (45%) were juxtaanastomotic, and 12 
(55%) were fibroric midgraft valve sites. These 
lesions were also detected early: 16 (73%) of 22 
by 6 weeks and 20 (9i%) of 22 by 3 months. Thus 
91% of stenoses subsequently requiring repair arose 
at sites of flow disturbance present and detectable 
within the first 3 postoperative months. Lesions 
destined to progress in severity tended to do so 
within 3 to 6 months of detection; the mean i terval 
from detection to repair was 5 months. Only two 
(9%) lesions had de novo development without 
early underlying flow disturbances. Table II sum- 
marizes the incidence of revision based on conduit 
type. No difference was seen in the incidence of 
stenosis requiring revision for reversed or in situ 
greater saphenous vein grafts. Arm, alternate, and 
spliced vein conduits exhibited a trend toward an 
increased incidence of significant stenosis, but this 
trend was not statistically significant. 
DISCUSSION 
A major unanswered clinical question concerns 
the origin of vein graft stenoses. At reoperation the 
most commonly identified h~stopathologic lesion is 
focal myointimal hyperplasia either in the body of the 
graft at a valve site or immediately adjacent to the 
proximal or distal anastomosis.12 Previous work with 
intraoperative color-duplex imaging documented a 
spectrum of flow abnormalities in 34% of infrain- 
guinal vein bypass grafts. 13 We recently reported the 
results of a series of arterial reconstructions subjected 
to intraoperative duplex scanning and noted that 
early (< 30 day) occlusion or requirement for revi- 
sion was extremely uncommon in reconstructions 
without residual flow disturbances.14 This study was 
an extension of duplex surveillance in which we 
sought o identify and determine the natural history 
of flow disturbances detected uring the operation 
and early after the operation within infrainguinal vein 
conduits. 
This study identified early focal flow disturbances 
in 33% of 135 vein grafts. Of considerable interest 
are the 16 grafts with lesions that resolved completely 
without the need for revision. Fifteen of these flow 
disturbances were detected on at least two separate 
duplex scans obtained at least 6 weeks apart. Most of 
these lesions were mild to moderate flow distur- 
bances (Table I) appearing in the midgraft segments 
of reversed vein grafts. We speculate that these flow 
disturbances occurred at sites of normal valves and 
resolved as the valve leaflets contracted or adhered to 
the vein graft wall. Lesions destined to resolve did so 
during a relatively short time frame, averaging only 
3.6 months. Although resolution of early flow 
disturbances has been reported after carotid endar- 
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Table II. Number and location of duplex lesions identified and revised relative to graft type 
Greater saphenous vein 
Graft segment Rev ISVB Non-rev Spliced veins Cephalic vein 
Proximal anastomotic graft (n = 13) 3/8 3/4 - 
High-thigh segment (n = 8) 1/5 0/1 - 
Above-knee segment (n = 12) 2/8 1/1 2/2 
Below-knee segment (n = 7) 0/1 0/1 1/1 
Distal anastomotic graft (n = 9) 0/1 2/6 2/2 
Totals 6/23 6/13 5/5 
Percent revised 26 46 100 
0/1 
0/2 
1/1 
3/3 
4/7 
57 
1/1 
1/1 
lOO 
Ree, Reversed saphenous vein; ISVB, in situ saphenous vein; Non-rev, nonreversed translocated vein. 
*Data expressed as no. of lesions revised/total lesions. 
terectomy, is to our knowledge this is the first report 
documenting resolution of such stenoses in infrain- 
guinal vein grafts. 
A significant proportion of early flow distur- 
bances did not resolve; 45% progressed uring a 
mean interval of 5 months and required intervention. 
These data are consistent with the report of Grigg et 
al.,16 who analyzed a series of 80 in situ vein grafts 
and observed that duplex-detected l sions that pro- 
gressed id so within 3 months. Early focal flow 
disturbances thus harbor significant potential for 
progression tohemodynamic graft stenosis. Our data 
also indicate that resolution or progression of these 
early flow abnormalities took place during a short 
time frame that lasted no longer than 3 to 5 months. 
This time interval is consistent with available infor- 
mation concerning the response of vein grafts to 
implantation and arterialization. Areas of initial 
deendothelialization that occur during implantation 
of both in situ and reversed veins heal within 2 to 6 
weeks. 1718 In an experimental model smooth-muscle 
cell replication i  the vein graft wall increases rapidly 
after implantation i the arterial circuit; it reaches a
maximum at 1 to 4 weeks and is nearly quiescent by 
12 to 24 weeks. ~9 The response of the vein graft at the 
site of the flow disturbance, either healing or 
progression, thus occurs during the early adaptation 
of the vein to the hemodynamics of arterial flow. 
Our data clearly suggest hat early flow distur- 
bances are a marker for graft stenosis. Grafts lacking 
such flow abnormalities rarely (< 3%) develop sig- 
nificant graft stenosis in the intermediate postoper- 
ative time interval. In contrast nearly half of grafts 
harboring an early flow disturbance (PSV > 150 
cm/sec, Vr > 1.5) subsequently develop graft stenosis 
at the site of that flow disturbance. The data are 
presently insufficient o determine whether these 
focal flow disturbances are present from the moment 
of graft implantation and therefore represent preex- 
isting conduit abnormalities and technical defects or 
whether they develop soon after graft implantation 
and represent the vein graft response to injury and 
arterialization. In the former instance the hemody- 
namic perturbation present from the outset is respon- 
sible for initiating the local cellular mechanisms that 
result in smooth-muscle c ll replication and myoin- 
timal hyperplasia. Alternatively the flow disturbances 
could be the result of an early proliferative r sponse 
in the vein graft associated with platelet deposition 
and activation or increased smooth-muscle mass. In 
either case early duplex scans obtained within the first 
3 months of graft implantation will identify more 
than 90% of the lesions destined to develop into 
graft-threatening stenoses. 
Previous reports, 6'2°-21 including our own, 2,22 
indicated that the intermediate postoperative inter- 
val, from 3 to 18 months, was the critical time period 
during which graft stenoses develop. Surveillance 
studies in nearly all these reports, however, were not 
begun before 6 weeks and usually not until 3 months. 
Such reports thus shed no light on the origin of these 
early appearing lesions. This study indicates that 
precursors or markers of graft stenosis are present 
within the first 6 to 12 weeks after graft implantation 
and that these lesions will declare themselves by 
resolution or progression within a relatively short 3- 
to 5-month period. The data also suggest that when 
greater saphenous vein is used and carefully prepared 
either in the reverse or in situ configuration, no 
difference is seen in the incidence of significant graft 
stenosis (12% to 13 %). Arm veins and spliced venous 
conduits may be at sufficiently increased risk for 
stenosis and therefore warrant closer surveillance. 
These observations are of potential clinical sig- 
nificance. Vein grafts with normal early scans appear 
to be at low risk for the development of graft stenosis 
and unexpected thrombosis. If this conclusion is 
confirmed uring more extensive follow-up exami- 
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nation o f  patients who have undergone infrainguinal 
bypass, we will be able to recommend less intensive 
surveillance in this patient subgroup. In contrast 
grafts with abnormal early duplex scans in which focal 
flow disturbances are noted require closer observa- 
tion. Scans should be performed at more frequent 
intervals (every 6 to 8 weeks) for 3 to 6 months to 
identify lesions that are progressive before graft 
thrombosis. 
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DISCUSSION 
Dr. Gregory L. Moneta (Portland, Ore.). I believe the 
authors have made some interesting observations pertain- 
ing to early vein graft failure. Based on their data they imply 
that routine intraoperative and perioperative surveillance is
important for vein grafts and that grafts with velocities 
greater than 150 cm/sec deserve intensive surveillance, 
whereas those with normal perioperative duplex examina- 
tion results require less late scrutiny. 
I think we all believe that perioperative graft failure, for 
the most part, results from technical errors or implanting a
poor-quality vein. Certainly spliced grafts, and grafts of 
poor-quality vein, and, as the Brigham group showed us 3 
years ago (J VASC SURG 1992;15:113-20), in situ grafts, 
may be more prone to a surgical error requiring early graft 
revision. 
Did most of the grafts you revised have relatively severe 
early flow abnormalities that persisted, that is, more than 
about 200 to 250 cm/sec, or were they mild abnormalities 
that progressed? 
Second, how many of the persistent velocity increases 
in your reverse grafts were really surprises, that is, they 
occurred in ~i single-segment reverse graft of good quality? 
JOURNAL OF VASCULAR SURGERY 
Volume 21, Number 1 Mills et al. 23 
In our practice reverse grafts truly at risk for early failure 
seem predictable atthe time of operation without extensive 
intraoperative imaging studies. Currently, unless there is a 
suspected problem, we usually limit intraoperative evalu- 
ation of our reverse vein grafts to a continuous-wave 
Doppler examination. 
It is incorrect o conclude from your data and short 
follow-up that grafts without early flow abnormalities 
require less late surveillance. At Oregon, although we do 
not do intraoperative duplex scanning and rarely obtain 
completion angiography, we do have an active program of 
ongoing postoperative surveillance with duplex scanning. 
Of 50 revisions that we have performed at our university 
hospital during a 5-year period, 26 of the 50 grafts revised 
were revised more than a year after the initial operation. 
Some had up to seven normal surveillance xaminations 
before an abnormality was discovered. I suspect hat as 
your series matures and follow-up increases, more late 
problems will be found in grafts with normal early 
examination results. I urge you to consider that although a
good graft will do well early, it may not necessarily stay that 
way indefinitely. After all, thus far, no biologic system has 
proved immortal. 
In summary I believe this article confirms our suspi- 
cions regarding the causes of early graft failure. It is, 
however, wrong to extrapolate he data and conclude that 
intermediate and late failures are precluded by early, normal 
postoperative surveillance examinations. I agree that grafts 
at risk for early failure must be monitored closely. Keep in 
mind, however, that a surveillance program based on 
duplex scanning probably increases overall graft patency by 
no more than 20% to 25%. The total long-term surveil- 
lance effectiveness will be hindered, if you become com- 
placent about normal, early results. 
Dr. Joseph L. Mills. If  I could make one point and 
then answer the questions in sequence. This study did not 
address early failure but addressed intermediate and long- 
term results after graft implantation. In the series of grafts 
that we did with normal intraoperative duplex scans, we 
had no early failures, and in the entire series we had only 
two early failures, so this study was about what happens to 
these grafts down the road. 
As far as whether these lesions were severe, persistent 
lesions or had progressed, only one lesion was identified 
early after the operation and was fixed immediately because 
of severity. All the other lesions were monitored to see 
whether they progressed, because when we started this 
early surveillance protocol, we had no idea what sort of 
abnormalities we were going to see and which ones would 
progress. 
As far as which ones were surprising versus which ones 
were not, they were all surprises. We scan every graft during 
the operation, and we try to leave the operating room with 
a perfect graft. Now you cannot do that. You are going to 
find a spectrum of abnormalities, and then you are going to 
have to decide which lesions you leave alone, and so we left 
the operating room with five grafts in which we detected 
moderate flow disturbances. Despite this intensive arly 
surveillance, we still had this striking incidence of lesions 
appearing in the first 1- and 6-week scans. 
The final question about the time of revision, if you 
look at our incidence of graft stenosis, it is identical to 
everything that has ever been reported, and all we have 
done is move up the time frame. All previous eries had 
defined graft stenosis by the time the graft was revised. 
Those authors did not address the time the lesion first 
appeared, for the most part. We followed these lesions 
along to monitor them for progression, and we got 
uncomfortable when the lesions serially progressed to a 
certain point and intervened. But our graft stenosis rate is 
exactly that which we previously reported and which has 
been reported from multiple other centers, so I do not think 
we are fixing lesions that should not be fixed. 
As far as your observation that grafts have repetitive 
normal scans, and then boom, there is a stenosis, that 
directly conflicts with previous data that we have reported 
in a combined series with your group from Oregon. In that 
series, which was published in the JOURNAL OF VASCULAR 
SURGERY in 1990, we noted that in 379 reverse grafts only 
2% had serial normal scans that developed stenosis. So the 
point of this study is that normal grafts do not get stenosis; 
they develop either from early appearing or preexisting 
areas of abnormality in the conduit. This appears to hold 
true at least for the intermediate postoperative p riod of 2 
to 3 years. 
Dr. Alexander W. Clowes (Seattle, Wash.) I want to 
focus on your observation that there are some early changes 
in vein grafts and to note that you see progression i some 
grafts but regression i  others. In animal studies at 1 week 
there is extremely little intimal thickening in vein grafts, 
and thrombus is often present. Your observations are 
compatible with the notion that there are small accumu- 
lations of thrombus. Sometimes they may lyse, whereas at 
other times they may become organized and develop into 
scar tissue. Do you in fact have evidence to support he 
possibility that there are small accumulations of thrombus 
that become scar tissue, and therefore do you find defects 
that would be prone to thrombosis uch as fragments of 
residual valve? 
Dr. Mills. We are extremely interested in that. The 
problem is that we do not have histopathologic informa- 
tion on any of the lesions until they are revised, so when we 
find an early abnormality, I suspect that some of these are 
areas of platelet aggregation or that some such process is 
occurring, but because we do not know what those lesions 
look like or have a ready way to look at them until we 
intervene, it is hard to know what is going on. But I think 
a key thing to look at in the future would be to try to 
determine whether there is some way to predict which o f  
these lesions are going to progress. 
Mr. John H. N. Wolfe (London, United Kingdom). 
I particularly enjoyed this article, which is, I believe, one of 
the most significant contributions to this topic for some 
years. The results of our own series are almost identical to 
JOURNAL OF VASCULAR SURGERY 
24 Mills et al. January 1995 
yours in terms of the very early development of graft 
stenosis, but the most important aspect of your study is that 
there is a local lesion in the vein that goes on to form a 
stenosis. This is slightly at odds with some of our own work 
on the development of these stenoses; we have cultured the 
smooth-muscle c lls from these stenoses and from normal 
veins and have found that they respond in a different way 
to heparin. Furthermore the heparin-resistant cells can be 
found in the normal vessels of a patient in whom a stenosis 
has developed. This suggests ome predisposition i the 
patient rather than in the segment of vein used. Do you 
think this is in conflict with your own data? 
Dr. Mills. Those are interesting observations, and we 
are aware of both your work and Mr. Harris' work from 
England that clearly shows that most of these lesions, if you 
follow them carefully, show up in the first year. There may 
be some difference in patient susceptibility, but what 
interests me is that most of these lesions are solitary, and 
either they go away or you fix them, but they do not come 
back. We have a few patients who get repetitive l sions or 
recurrent lesions, and we wonder what is going on in these 
patients. 
But clearly your observations fit with ours. It may be 
that when you have some early appearing conduit abnor- 
mality or vein defect, certain patients respond to that 
differently than others. And that is something that is 
worthy of further research. 
Dr. John A. Mannick (Boston, Mass.). Dr. Moneta 
quoted our group as presenting data indicating that in situ 
vein grafts had more failures from intrinsic lesions than did 
reversed vein grafts, and we certainly did not think we 
showed that. He perhaps is referring to the fact that in data 
that were presented from Oregon, I think, by Dr. Mills, the 
failure rate for reversed grafts was commendably low. But 
there was about a 10% failure rate in which the cause was 
unknown. The causes of failure in the series reported from 
the Brigham group were known, and I think that it is unfair 
to say that any difference has been demonstrated between 
the intrinsic failure rate in reversed and in situ grafts. This 
study confirms this conclusion. 
Dr. David A. Brewster (Boston, Mass.). Most of the 
previous literature on surveillance relates to in situ grafts 
whose subcutaneous position lends itself nicely, of course, 
to interrogation and revision. In your series I noted at least 
half of your cases were reversed vein grafts. From a practical 
standpoint, can you just share with us whether duplex 
scanning to follow such reversed grafts is more difficult? 
Also, if revision of reversed vein grafts is necessary, is it 
technically more difficult than with subcutaneous in situ 
grafts ?
Dr. Mills. When we first started oing graft scans, we 
had a black-and-white duplex scanner, and we did not scan 
the whole graft, but only portions of the graft. I think with 
the advent of color it has made it much easier to look at 
these grafts in their entirety. It also depends on where the 
graft is placed. Many of our patients are patients undergo- 
ing reoperation, and we will often tunnel what we 
perceive to be a high-risk graft at subcutaneous examina- 
tion. The only scan that may be more difficult to do in 
patients with reversed vein grafts who have deeply placed 
grafts is the 1-week scan and sometimes the 6-week scan, 
because the leg will be edematous, and particularly if you 
go to a peroneal artery or come offthe profunda, it may be 
harder to obtain an image of some of these areas. That is 
why we are not always ure whether these lesions that crop 
up at 6 weeks were there at 1 week, and we missed them. 
Our technicians have gotten quite good at finding our 
grafts, and they are also quite good at finding defects in our 
grafts. 
The other thing that we have noted is that vein is vein. 
If  you have a good conduit, you can get a good result with 
either operation. The one thing that is interesting is that 
most of these minor flow disturbances that went away 
seemed to occur in reverse grafts, and my feeling is that 
probably these are normal valves that have a little flow 
disturbance before they adhere or contract. But other than 
that we have not really noticed any major differences in the 
type of lesions identified or their incidence. 
Dr. Frank W. Lo Gerfo (Boston, Mass.). Dr. Mills, I 
would like to compliment you on what I think is a really 
excellent addition to the literature. I think this is the first 
report of good documentation f  regression of stenosis of 
vein grafts in any significant series, and I think that is very, 
very important. 
I have a couple of questions for you. It was not clear to 
me: during the operation when you do the duplex scan, 
how often do you have to do an intraoperative r vision of 
your procedure? I wonder if you would comment on that, 
and second, based on this, what are your overall recom- 
mendations for surveillance protocols? I am in a little 
quandary about this, because we do not do routine 
postoperative duplex surveillance of our vein grafts, and I 
do not see a big difference between our results and the 
results of others. We do listen over the graft with a 
handheld Doppler radar, and I would submit, with a 
velocity ratio of 3 : 4, few surgeons in this room who use a 
simple Doppler radar could not detect it by carefi,fl 
examination. I think that has to be the standard against 
which any surveillance protocol is compared, for one thing 
because of the cost involved. I am not criticizing your 
study, because you have made valuable contributions based 
on the information you have gained here, but for the 
general surveillance, I wonder what your recommendations 
are. 
Dr. Mills. I will address those in order. First of all we 
need to be careful what we term this regression. I am not 
sure we can call it regression. We can call it resolution of the 
flow abnormality, but because we do not know what these 
early lesions represent, it is unclear whether something 
was there that actually regressed, or a flow disturbance 
resolved. 
As far as the frequency of intraoperative r vision, it 
depends on the indication for surgery. For our tibial grafts 
in probably 10% to 15% of our grafts we find something 
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in the conduit we have to repair, or we revise an 
anastomosis. 
As far as our overall recommendations, I think mukiple 
studies have carefully shown that 20% of these grafts 
develop lesions, as was demonstrated 30 years ago by Dr. 
Szilagyi. When you monitor these grafts the intrinsic graft 
stenoses progress, and if you do not intervene, those grafts 
thrombose. Although our series is relatively oung, we 
have only had six grafts fail during follow-up, and all those 
had some identified abnormality that either we elected to 
follow or the patient refused intervention. I really think that 
when you follow these grafts very, very carefully, you can 
prevent most graft thromboses. 
What we are trying to do with these early scans is see 
whether there is a way to separate grafts into high-risk and 
low-risk groups, and if you can do that, you can focus all 
your surveillance attention on the higher risk groups and 
subject he other grafts, which are probably two thirds of 
the grafts, to much less intensive surveillance. 
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